|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Multidrug resistance in small cell lung cancer:expression of P-glycoprotein,multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease显示文摘 | Triller N Korosec P Kern I | | 0，，： | 1 |
| 2 | Talc pleurodesis: comparison of talc slurry instillation with thoracoscopic talc in sufflation for malignant pleural effusions显示文摘 | Debeljak A Kecelj P Triller N | 2006 | J BUON2006，11，4： | 1 |
| 3 | Prospective molecular marker analyses of EGFR and KRAS from a randomized,placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer显示文摘 | Brugger W Triller N Blasinska-Morawiec M | | 0，，31： | 1 |
| 4 | Outcome of small cell lung cancer (SCLC) patients with brain metastases in a routine clini- cal setting显示文摘 | Lekic M Kovac V Triller N | 2012 | Radiol Oncol2012，46，： | 1 |
| 5 | Biomarker analyses from the phase Ⅲ placebo-controlled SATURN study of maintenance erlotinib following first-line chemotherapy for advanced NSCLC显示文摘 | Brugger W Triller N Blasinska-Morawiec M | | 0，，8020： | 1 |
| 6 | Prospective molecular marker analyses of EGFR and KRAS from a randomized,placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer显示文摘 | Brugger W Triller N Blasinska-Morawiec M | | 0，，31： | 1 |
| 7 | Multidrug resistance in small cell lung cancer:expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease 显示文摘 | Triller N Korosec P Kern I | 2006 | Lung Cancer2006，54，： | 1 |
| 8 | Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer 显示文摘 | BRUGGER W TRILLER N BLASIBSKA-MORAWIEC M | 2011 | J Clin Oncol2011，29，31： | 1 |
| 9 | Multidrug resistance in small cell lung cancer: Expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease 显示文摘 | TRILLER N KOROSEC P KERN I | 2006 | Lung Cancer2006，54，2： | 1 |
| 10 | Prospective molecular marker analyses of EGFR and KRAS from a random- ized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small cell lung cancer显示文摘 | Brugger W Triller N Blasinska-Morawiec M | 2011 | j ClinOncol2011，29，31： | 1 |
| 11 | Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer显示文摘 | Brugger W Triller N Blasinska-Morawiec M | 2011 | J Clin Oncol2011，29，31： | 1 |
| 12 | Prospec- tive molecular marker analyses of EGFR and KRAS from a randomized,placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer显示文摘 | Brugger W Triller N Blasinska-Morawiec M | 2011 | J Clin On- col2011，29，31： | 1 |
| 13 | Multidrug resistance in small cell lung cancer:expression of P-glycoprotein,multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease显示文摘 | Triller N Korosec P Kern I | | 0，，02： | 1 |
| 14 | Prospective molecular marker analyses of EGFR and KRAS from a randomized,placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer显示文摘 | BRUGGER W TRILLER N BLASINSKA-MORAWIEC M | | 0，，31： | 1 |
| 15 | Multidrug resistance in small cell lung cancer:expression of P-glycoprotein,multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease显示文摘 | Triller N Korosec P Kern I | 2006 | Lung Cancer2006，54，2： | 1 |
| 16 | Outcome of small cell lung cancer (SCLC) patients with brain metastases in a routine clinical setting显示文摘 | Lekic M Kovac V Triller N | 2012 | Radiology and oncology2012，46，1： | 1 |
| 17 | Multidrug resistance in small celllung cancer:expression of P-glycoprotein,multidrug resistance pro-tein 1 and lung resistance protein in chemo-naive patients and in re-lapsed disease显示文摘 | Triller N Korosec P Kern I | 2006 | Lung Cancer2006，54，2： | 1 |
| 18 | Multidrug resistance in small cell lung cancer: expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease显示文摘 | Triller N Korosec P Kern I | 2006 | Lung Cancer2006，54，2： | 1 |
| 19 | Multidrug resistance in smaU cell lung cancer: expression of P - glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemonaive patients and in relapsed disease显示文摘 | Triller N Korosee P Kern I | 2006 | Lung Cancer2006，54，2： | 1 |
| 20 | Muhidrug resistance in small cell lung cancer: expression of P glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease显示文摘 | Triller N Korosec P Kern I | 2006 | Lung Cancer2006，54，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员